Page 101 - AIH-1-2
P. 101

Artificial Intelligence in Health                               Combating XDR-bacteria as we approach 2050



            52.  Fields FR, Lee SW, McConnell MJ. Using bacterial genomes      doi: 10.2174/1872210513666190308133429
               and essential genes for the development of new antibiotics.   57.  Tarín-Pelló A, Suay-García B, Pérez-Gracia MT. Antibiotic
               Biochem Pharmacol. 2017;134:74-86.
                                                                  resistant bacteria: Current situation and treatment options
               doi: 10.1016/j.bcp.2016.12.002                     to  accelerate  the  development  of  a  new  antimicrobial
                                                                  arsenal. Expert Rev Anti Infect Ther. 2022;20(8):1095-1108.
            53.  Rana R, Awasthi R, Sharma B, Kulkarni GT. Nanoantibiotic
               formulations to combat antibiotic resistance  -  old      doi: 10.1080/14787210.2022.2078308
               wine in a new bottle.  Recent Pat Drug Deliv Formul.   58.  Lv S, Wang Y, Jiang K,  et al. Genetic engineering and
               2019;13(3):174-183.
                                                                  biosynthesis technology: Keys to unlocking the chains of
               doi: 10.2174/1872211313666190911124626             phage therapy. Viruses. 2023;15(8):1736.
            54.  Munir MU, Ahmed A, Usman M, Salman S. Recent advances      doi: 10.3390/v15081736
               in nanotechnology-aided materials in combating microbial
               resistance  and  functioning as  antibiotics  substitutes.  Int J   59.  Zeituni EM, Raterman EL. NIAID’s comprehensive support
               Nanomedicine. 2020;15:7329-7358.                   mechanisms for antibiotic development.  ACS  Infect  Dis.
                                                                  2020;6(6):1299-1301.
               doi: 10.2147/IJN.S265934
                                                                  doi: 10.1021/acsinfecdis.0c00099
            55.  Manrique PD, López CA, Gnanakaran S, Rybenkov VV,
               Zgurskaya HI. New understanding of multidrug efflux   60.  Lluka  T,  Stokes JM.  Antibiotic discovery in  the  artificial
               and permeation in antibiotic resistance, persistence, and   intelligence era. Ann N Y Acad Sci. 2023;1519(1):74-93.
               heteroresistance. Ann N Y Acad Sci. 2023;1519(1):46-62.     doi: 10.1111/nyas.14930
               doi: 10.1111/nyas.14921                         61.  Xavier BB, Das AJ, Cochrane G,  et al. Consolidating and
                                                                  exploring antibiotic resistance gene data resources.  J  Clin
            56.  Mulat M, Pandita A, Khan F. Medicinal plant compounds
               for combating the multi-drug resistant pathogenic bacteria:   Microbiol. 2016;54(4):851-859.
               A review. Curr Pharm Biotechnol. 2019;20(3):183-196.     doi: 10.1128/JCM.02717-15














































            Volume 1 Issue 2 (2024)                         95                               doi: 10.36922/aih.2284
   96   97   98   99   100   101   102   103   104   105   106